Atlantis Glory Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Atlantis Glory Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $156.0K | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | $0 | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | $10.5K | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $21.0K | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | $0 | Oct 13, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $38.9K | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | $0 | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | $7.7K | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $17.0K | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | $0 | Oct 13, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($39.2K) | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($40.5K) | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | ($68.0K) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $8.27M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($282.8K) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($1.62M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($3.84M) | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | ($20.1K) | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | ($29.6K) | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $5.8K | Sep 24, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($68.0K) | Mar 13, 2024 |
| FY2023 | Dec 31, 2022 | ($62.3K) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($282.8K) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($79.0K) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($4.07M) | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | ($20.1K) | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | $29.6K | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $5.8K | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | ($758) | Oct 13, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $1.65M | Aug 24, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($34.1K) | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($40.5K) | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | ($55.6K) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($65.0K) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($32.2K) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($79.0K) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($3.17M) | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | ($25.9K) | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | $26.3K | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $6.1K | Sep 24, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2019 | $205.3K | Aug 24, 2021 |
| FY2018 | Jun 30, 2018 | ($6.0K) | Sep 24, 2018 |
| FY2018 | Jun 30, 2017 | ($5.1K) | Sep 24, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $9.0K | Mar 13, 2024 |
| FY2020 | Dec 31, 2019 | $3.77M | Aug 24, 2021 |
| FY2018 | Jun 30, 2018 | $17.2K | Sep 24, 2018 |
| FY2018 | Jun 30, 2017 | $43.0K | Sep 24, 2018 |
| FY2017 | Jun 30, 2016 | $6.1K | Oct 13, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $210.6K | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | $171.4K | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | $130.9K | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | $71.9K | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | $8.33M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | $8.36M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | $8.28M | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | $14.1K | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | $17.2K | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $5.9K | Sep 24, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($210.6K) | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($171.4K) | Mar 6, 2026 |
| FY2025 | Dec 31, 2023 | ($130.9K) | Mar 6, 2026 |
| FY2024 | Dec 31, 2022 | ($62.9K) | Mar 25, 2025 |
| FY2023 | Dec 31, 2021 | ($8.33M) | Mar 13, 2024 |
| FY2022 | Dec 31, 2020 | ($8.36M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2019 | ($4.50M) | Mar 15, 2022 |
| FY2019 | Jun 30, 2019 | ($12.5K) | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | $7.6K | Aug 23, 2019 |
| FY2019 | Jun 30, 2017 | $37.2K | Aug 23, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.15M) | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | ($1.11M) | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | ($1.07M) | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | ($998.7K) | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | ($9.27M) | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | ($8.99M) | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | ($5.51M) | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | ($44.6K) | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | ($24.5K) | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $5.1K | Sep 24, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | Mar 6, 2026 |
| FY2024 | Dec 31, 2024 | $0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2023 | $0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2022 | $0 | Mar 17, 2023 |
| FY2020 | Dec 31, 2020 | $0 | Aug 24, 2021 |
| FY2021 | Dec 31, 2019 | $1.54M | Mar 15, 2022 |
| FY2019 | Jun 30, 2019 | $408 | Aug 23, 2019 |
| FY2020 | Dec 31, 2018 | $187.9K | Aug 24, 2021 |
| FY2019 | Jun 30, 2018 | $9.8K | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | $38.2K | Sep 24, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $64.5K | Mar 17, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 17, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 13, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 603.97M | Mar 6, 2026 |
| FY2025 | Dec 31, 2024 | 603.97M | Mar 6, 2026 |
| FY2024 | Dec 31, 2023 | 603.97M | Mar 25, 2025 |
| FY2023 | Dec 31, 2022 | 603.97M | Mar 13, 2024 |
| FY2022 | Dec 31, 2021 | 603.97M | Mar 17, 2023 |
| FY2021 | Dec 31, 2020 | 603.97M | Mar 15, 2022 |
| FY2020 | Dec 31, 2019 | 603.97M | Aug 24, 2021 |
| FY2019 | Jun 30, 2019 | 3.97M | Aug 23, 2019 |
| FY2019 | Jun 30, 2018 | 3.97M | Aug 23, 2019 |
| FY2018 | Jun 30, 2017 | 3.97M | Sep 24, 2018 |